Taipei Veterans General Hospital is a national first-class medical center and a teaching hospital that provides tertiary patient care, undergraduate medical education programs and residency programs in Taiwan. It was founded in 1958 and administered by the Veterans Affairs Council.

During the past decade, Clinical Trial Pharmacy, Taipei Veterans General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinical Trial Pharmacy, Taipei Veterans General Hospital" are "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Clinical Trial Pharmacy, Taipei Veterans General Hospital" in a lesser frequency.

Most popular intervention types in "Clinical Trial Pharmacy, Taipei Veterans General Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "PLD" (1 trials), "avelumab" (1 trials), "carboplatin" (1 trials) and "paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trial Pharmacy, Taipei Veterans General Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Trial Pharmacy, Taipei Veterans General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinical Trial Pharmacy, Taipei Veterans General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trial Pharmacy, Taipei Veterans General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".